Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.56EUR
23 Oct 2018
Change (% chg)

-- (--)
Prev Close
€70.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
698,228
52-wk High
€93.82
52-wk Low
€68.10

Chart for

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €25,665.52
Shares Outstanding(Mil.): 307.96
Dividend: 0.96
Yield (%): 1.15

Financials

  FMEG.DE Industry Sector
P/E (TTM): 20.57 28.18 33.64
EPS (TTM): 4.05 -- --
ROI: 8.40 6.90 14.27
ROE: 13.39 11.00 15.99

UPDATE 1-Fresenius Medical cuts 2018 targets, sending shares tumbling

* FMC shares slump 13.7 pct, Fresenius down 8.9 pct (Recasts, adds outlook, analyst, trader comment, changes dateline)

17 Oct 2018

FMC takes stake in Humacyte in bet on bioengineered blood vessel

FRANKFURT Germany's Fresenius Medical Care (FMC) has agreed to take a $150 million (112.3 million pounds) stake in U.S. tissue engineering firm Humacyte Inc. and will become the exclusive distributor of the company's bioengineered blood vessels once they win approval.

11 Jun 2018

FMC takes stake in Humacyte in bet on bioengineered blood vessel

FRANKFURT Germany's Fresenius Medical Care (FMC) has agreed to take a $150 million stake in U.S. tissue engineering firm Humacyte Inc. and will become the exclusive distributor of the company's bioengineered blood vessels once they win approval.

11 Jun 2018

FMC takes stake in Humacyte in bet on bioengineered blood vessel

FRANKFURT, June 11 Germany's Fresenius Medical Care (FMC) has agreed to take a $150 million stake in U.S. tissue engineering firm Humacyte Inc. and will become the exclusive distributor of the company's bioengineered blood vessels once they win approval.

11 Jun 2018

BRIEF-Fresenius Medical Care CEO: Looking To Pick-Up M&A Pace

* CEO TELLS Q1 ANALYST CALL WE ARE LOOKING TO BE MORE ACTIVE IN THE ACQUISITION ARENA; IT'S SMALL THINGS Further company coverage: (Reporting By Berlin Newsroom)

03 May 2018

Earnings vs. Estimates